Latest Shareholder Dilution News

Macarthur Minerals has updated the timetable for its pro-rata renounceable rights issue, providing shareholders with more time to participate in the A$2 million capital raise. The offer terms remain unchanged as the company awaits regulatory approval for a supplementary prospectus.

Many Peaks Minerals Limited has retained its option to acquire 100% of the Baga Gold Project in Côte d’Ivoire, advancing exploration with amended payment terms that blend cash and shares.

South Harz Potash Ltd has announced a pro-rata non-renounceable entitlement issue to raise approximately A$1.28 million, offering one new share for every three held plus free options. The capital raise aims to fund its dual-asset growth plans in Germany amid ongoing project development and acquisition efforts.

Noble Helium has arranged a $200,000 unsecured loan from its Non-Executive Chair as a short-term refinancing measure, aiming to bolster working capital without diluting shareholders. The company plans a webinar to outline its refinancing and strategic direction.

Mount Burgess Mining has raised $221,806 through a share placement aimed at advancing its Kihabe-Nxuu Project and supporting ongoing operations.

Zenith Minerals has opened a fully underwritten $3.5 million entitlement offer, inviting shareholders to subscribe for new shares with free attaching options, aiming to bolster its gold and lithium exploration projects.

Keybridge Capital has lodged formal applications with the Takeovers Panel contesting Yowie Group’s off-market takeover offer, citing alleged legal circumvention and disclosure issues. The dispute raises questions about control dynamics and shareholder rights in the unfolding corporate tussle.

Bass Oil Limited has raised $925,180 through a non-renounceable rights issue, aiming to complete its Vanessa Acquisition and fuel future growth initiatives.

Bastion Minerals Limited (ASX, BMO) has announced a non-renounceable entitlement offer to raise approximately $677,721 by issuing new shares at a low price of $0.001 each. The capital raise aims to support ongoing project evaluations and working capital needs.

Recce Pharmaceuticals has locked in a non-dilutive A$30 million debt facility with Avenue Capital Group, extending its cash runway to support pivotal Phase 3 trials and commercialisation of its synthetic anti-infective R327G.

Vanadium Resources Limited has signed a non-binding MoU with China Precious Asia Limited to supply 1.2 million tonnes per annum of vanadium-rich magnetite ore, marking a strategic step toward near-term production and early cashflow generation from its Steelpoortdrift project.

Tempest Minerals has completed a pro-rata entitlement offer, raising over $600,000 to fund exploration in Western Australia, though a significant shortfall remains to be allocated.